Likewise, immunosuppressive cells take advantage of CCR7 to locate themselves close to innate or adaptative anti-tumor immune cells, thus facilitating their tolerogenic or their inhibitory participation in the TME. This evidence concerns the gene CCR7 and neoplasm.